Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.68 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6464207 | 1.00 | TDP1 (0.68) | TDP1ABCB1POLBMAPK1ALDH1A1 | |
| SCHEMBL8117010 | 1.00 | TDP1 (0.68) | TDP1ABCB1POLBMAPK1ALDH1A1 | |
| SCHEMBL60323 | 1.00 | TDP1 (0.68) | TDP1ABCB1POLBMAPK1ALDH1A1 | |
| SCHEMBL8587285 | 1.00 | TDP1 (0.68) | TDP1ABCB1POLBMAPK1ALDH1A1 | |
| SCHEMBL2279600 | 1.00 | TDP1 (0.68) | TDP1ABCB1POLBMAPK1ALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL17061382 | 0.98 | TDP1 (0.66) | TDP1ABCB1POLBMAPK1 | |
| SCHEMBL60713 | 0.95 | TDP1 (0.71) | TDP1ABCB1POLBMAPK1 | |
| SCHEMBL13893402 | 0.95 | TDP1 (0.71) | TDP1ABCB1POLBMAPK1 | |
| SCHEMBL421756 | 0.95 | TDP1 (0.71) | TDP1ABCB1POLBMAPK1 | |
| SCHEMBL426635 | 0.95 | TDP1 (0.71) | TDP1ABCB1POLBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 520 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120192442-A | Preparation method of GalNAc compound containing ribosyl ring | 北京悦康科创医药科技股份有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-119613465-A | Chemical synthesis method of haemophilus influenzae type b capsular polysaccharide derivative | 江南大学 | 2025-03-14 | — | — | CN | claimed |
| CN-222566808-U | Alcohol recovery device during tetra-acetyl ribose is refined | 洛阳德胜生物科技股份有限公司 | 2025-03-07 | — | — | CN | claimed |
| US-12227534-B2 | Method for preparing nicotinamide mononucleotide by using nicotinamide as raw material | BONTAC BIO-ENGINEERING(SHENZHEN) CO., LTD. (CN) | 2025-02-18 | — | — | US | claimed |
| CN-114717280-B | Monopira Synthesis method of pyrrosia lingua | 浙江工业大学 | 2024-12-20 | — | — | CN | claimed |
| CN-119119146-A | New method for preparing 5-deoxidized triacetyl ribose | 启东东岳药业有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-119039362-A | Preparation method of beta-nicotinamide riboside chloride | 广东肇庆星湖生物科技股份有限公司 | 2024-11-29 | — | — | CN | claimed |
| CN-118994269-A | Preparation method of beta-nicotinamide mononucleotide | 上海昶法新材料有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-116375772-B | Preparation method and application of adenosine | 北京先通国际医药科技股份有限公司 | 2024-11-01 | — | — | CN | claimed |
| US-20240247022-A1 | A Process for Synthesis of Nicotinamide Riboside Chloride (NRCL) | BOHAN & CO AS. (NO) | 2024-07-25 | — | — | US | claimed |
| CN-111647032-A | Synthesis method of beta-nicotinamide mononucleotide | 上海舒泽生物科技研究所 | 2020-09-11 | — | — | CN | claimed |
| CN-108409818-B | Method for synthesizing cytosine nucleoside | 新乡拓新药业股份有限公司 | 2020-09-11 | — | — | CN | claimed |
| CN-111647033-A | Method for preparing ribavirin by one-pot method | 济南明鑫制药股份有限公司 | 2020-09-11 | — | — | CN | claimed |
| CN-109336937-B | Preparation method of ribavirin | 河南省科学院高新技术研究中心 | 2020-08-25 | — | — | CN | claimed |
| CN-111548383-A | Process for preparing beta-nicotinamide mononucleotide | 湖南和泰康瑞生物技术有限公司 | 2020-08-18 | — | — | CN | claimed |
| CN-111440170-A | Method for synthesizing guanine by using guanosine | 通辽德胜生物科技有限公司 | 2020-07-24 | — | — | CN | claimed |
| CN-111362944-A | Method for synthesizing diacetylacyclovir by using guanosine | 通辽德胜生物科技有限公司 | 2020-07-03 | — | — | CN | claimed |
| CN-111253448-A | Preparation method and purification method of β -nicotinamide mononucleotide | 上海昶法新材料有限公司 | 2020-06-09 | — | — | CN | claimed |
| CN-110642897-A | Preparation method of beta-nicotinamide riboside chloride | 武汉一若生物材料有限公司 | 2020-01-03 | — | — | CN | claimed |
| CN-106831916-B | synthetic method of beta-thymidine | 抚州市星辰药业有限公司 | 2019-12-06 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12227534-B2 | Method for preparing nicotinamide mononucleotide by using nicotinamide as raw material | NADK, NUDT1, NAMPT | TDP1 2571/4885ABCB1 2969/4885POLB 1120/4885 |
| US-20240247022-A1 | A Process for Synthesis of Nicotinamide Riboside Chloride (NRCL) | NAMPT, NAPRT, NNT | TDP1 3927/4885ABCB1 2956/4885POLB 3421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.